Ya Li

Changsha, 410208, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Traditional Chinese Medicine Intervention Based on Metabolic-Epigenetic Axis: Mechanism and Treatment Strategy of Chronic Heart Failure.

Traditional Chinese Medicine Intervention Based on Metabolic-Epigenetic Axis: Mechanism and Treatment Strategy of Chronic Heart Failure.

Journal: Biomolecules
Published: May 27, 2026

From Gut to Heart: Targeting Trimethylamine N-Oxide as a Novel Strategy in Heart Failure Management.

From Gut to Heart: Targeting Trimethylamine N-Oxide as a Novel Strategy in Heart Failure Management.

Journal: Biomolecules
Published: September 12, 2025

Sirtuins regulate macrophage polarization in heart failure: Metabolic reprogramming, epigenetic regulation, and immune cell interactions.

Sirtuins regulate macrophage polarization in heart failure: Metabolic reprogramming, epigenetic regulation, and immune cell interactions.

Journal: Pharmacological research
Published: March 31, 2025

Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases.

Preparation, Evaluation, and Bioinformatics Study of Hyaluronic Acid-Modified Ginsenoside Rb1 Self-Assembled Nanoparticles for Treating Cardiovascular Diseases.

Journal: Molecules (Basel, Switzerland)
Published: August 22, 2024

Targeting Macrophage Phenotype for Treating Heart Failure: A New Approach.

Targeting Macrophage Phenotype for Treating Heart Failure: A New Approach.

Journal: Drug design, development and therapy
Published: July 13, 2024

Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.

Biomembrane-Modified Biomimetic Nanodrug Delivery Systems: Frontier Platforms for Cardiovascular Disease Treatment.

Journal: Biomolecules
Published: July 10, 2024

Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction.

Advances in Nanoparticles in the Prevention and Treatment of Myocardial Infarction.

Journal: Molecules (Basel, Switzerland)
Published: March 26, 2024

Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure.

Network and Experimental Pharmacology on Mechanism of Yixintai Regulates the TMAO/PKC/NF-κB Signaling Pathway in Treating Heart Failure.

Journal: Drug design, development and therapy
Published: December 29, 2023

Integrating bioinformatics and ferroptosis to reveal the protective mechanism of Astragaloside IV on chronic heart failure rats.

Integrating bioinformatics and ferroptosis to reveal the protective mechanism of Astragaloside IV on chronic heart failure rats.

Journal: Scientific reports
Published: November 30, 2023

Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium.

Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium.

Journal: PloS one
Published: November 15, 2023

The role of the gut microbiota and bile acids in heart failure: A review.

The role of the gut microbiota and bile acids in heart failure: A review.

Journal: Medicine
Published: November 14, 2023

Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway.

Therapeutic Potential of Ginsenoside Rb1-PLGA Nanoparticles for Heart Failure Treatment via the ROS/PPARα/PGC1α Pathway.

Journal: Molecules (Basel, Switzerland)
Published: October 18, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026